List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 NGS-Based Monitoring and Diagnostic Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NGS-Based Monitoring and Diagnostic Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NGS-Based Monitoring and Diagnostic Test Overall Market Size
2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size: 2022 VS 2028
2.2 Global NGS-Based Monitoring and Diagnostic Test Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key NGS-Based Monitoring and Diagnostic Test Players in Global Market
3.2 Global Companies NGS-Based Monitoring and Diagnostic Test Product & Technology
4 Players Profiles
4.1 Agilent Technologies, Inc.
4.1.1 Agilent Technologies, Inc. Corporate Summary
4.1.2 Agilent Technologies, Inc. Business Overview
4.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.1.4 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.2 Ancestry.com LLC
4.2.1 Ancestry.com LLC Corporate Summary
4.2.2 Ancestry.com LLC Business Overview
4.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.2.4 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.3 ArcherDX, Inc.
4.3.1 ArcherDX, Inc. Corporate Summary
4.3.2 ArcherDX, Inc. Business Overview
4.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.4 Beijing Genomics Institute (BGI)
4.4.1 Beijing Genomics Institute (BGI) Corporate Summary
4.4.2 Beijing Genomics Institute (BGI) Business Overview
4.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.4.4 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.5 Cancer Genetics, Inc.
4.5.1 Cancer Genetics, Inc. Corporate Summary
4.5.2 Cancer Genetics, Inc. Business Overview
4.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.5.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.6 CENTOGENE AG
4.6.1 CENTOGENE AG Corporate Summary
4.6.2 CENTOGENE AG Business Overview
4.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.6.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.7 F. Hoffmann-La Roche Ltd
4.7.1 F. Hoffmann-La Roche Ltd Corporate Summary
4.7.2 F. Hoffmann-La Roche Ltd Business Overview
4.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.7.4 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.8 GenePath Dx
4.8.1 GenePath Dx Corporate Summary
4.8.2 GenePath Dx Business Overview
4.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.8.4 GenePath Dx NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.9 Illumina, Inc.
4.9.1 Illumina, Inc. Corporate Summary
4.9.2 Illumina, Inc. Business Overview
4.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.9.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.10 Laboratory Corporation of America Holdings
4.10.1 Laboratory Corporation of America Holdings Corporate Summary
4.10.2 Laboratory Corporation of America Holdings Business Overview
4.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.10.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.11 Myriad Genetics, Inc.
4.11.1 Myriad Genetics, Inc. Corporate Summary
4.11.2 Myriad Genetics, Inc. Business Overview
4.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.11.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.12 QIAGEN N.V.
4.12.1 QIAGEN N.V. Corporate Summary
4.12.2 QIAGEN N.V. Business Overview
4.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.12.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.13 Quest Diagnostics Incorporated
4.13.1 Quest Diagnostics Incorporated Corporate Summary
4.13.2 Quest Diagnostics Incorporated Business Overview
4.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.13.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.14 Siemens Healthineers, Inc.
4.14.1 Siemens Healthineers, Inc. Corporate Summary
4.14.2 Siemens Healthineers, Inc. Business Overview
4.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.15 Thermo Fisher Scientific Inc.
4.15.1 Thermo Fisher Scientific Inc. Corporate Summary
4.15.2 Thermo Fisher Scientific Inc. Business Overview
4.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.15.4 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.16 HTG Molecular Diagnostics, Inc.
4.16.1 HTG Molecular Diagnostics, Inc. Corporate Summary
4.16.2 HTG Molecular Diagnostics, Inc. Business Overview
4.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.16.4 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
4.17 Vela Diagnostics Pte. Ltd.
4.17.1 Vela Diagnostics Pte. Ltd. Corporate Summary
4.17.2 Vela Diagnostics Pte. Ltd. Business Overview
4.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Offerings & Technology
4.17.4 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test R&D, and Plans
5 Sights by Region
5.1 By Region - Global NGS-Based Monitoring and Diagnostic Test Market Size, 2023 & 2028
5.2 By Region - Global NGS-Based Monitoring and Diagnostic Test Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of NGS-Based Monitoring and Diagnostic Test in United States
5.3.2 United States NGS-Based Monitoring and Diagnostic Test Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of NGS-Based Monitoring and Diagnostic Test in Europe
5.4.2 Europe NGS-Based Monitoring and Diagnostic Test Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of NGS-Based Monitoring and Diagnostic Test in China
5.5.2 China NGS-Based Monitoring and Diagnostic Test Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global NGS-Based Monitoring and Diagnostic Test Market Size Markets, 2023 & 2028
6.2 Commercial Assays/Tests
6.3 Laboratory Developed Tests
6.4 Direct to Consumer Test
6.5 Pre-Commercial Tests
7 Sights by Application
7.1 By Application - Global NGS-Based Monitoring and Diagnostic Test Market Size, 2023 & 2028
7.2 Out-Patient Clinics/General Practitioners
7.3 Diagnostic Centers
7.4 Hospitals
7.5 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
